Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sanqi Huoluo Ointment is a topical Traditional Chinese Medicine (TCM) preparation developed by Guangzhou University of Chinese Medicine, primarily indicated for the treatment of acute closed soft tissue injuries. The formulation is centered on the pharmacological properties of *Panax notoginseng* (Sanqi), which is highly regarded in TCM for its ability to promote blood circulation, resolve blood stasis, and alleviate pain and swelling. The ointment works by delivering active saponins, such as notoginsenosides and ginsenosides, directly to the site of injury, where they modulate inflammatory pathways and improve local microcirculation. It is commonly used in clinical settings in China, particularly within orthopedic and sports medicine departments, to manage symptoms associated with sprains, contusions, and other musculoskeletal traumas.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sanqi Huoluo Ointment.